Showing results (461-470 of 686) with videos related to

Sort By:
Pageof 69
Journal of Chemotherapy (Florence, Italy)|July 26, 2005
Pharmacokinetics of bolus 5-fluorouracil: relationship between dose, plasma concentrations, area-under-the-curve and toxicityG Codacci-Pisanelli, H M Pinedo, J Lankelma, et al.
American Journal of Clinical Pathology|February 1, 1997
Effects of chemotherapy on pathologic and biologic characteristics of locally advanced breast cancerA H Honkoop, H M Pinedo, J S De Jong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
A dose-finding and pharmacokinetic study of reversal of multidrug resistance with SDZ PSC 833 in combination with doxorubicin in patients with solid tumorsG Giaccone, S C Linn, J Welink, et al.
Journal of the National Cancer Institute|December 20, 1989
Quantitative determination of factors contributing to doxorubicin resistance in multidrug-resistant cellsG J Schuurhuis, H J Broxterman, A Cervantes, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 1995
Thymidylate synthase and drug resistanceG J Peters, C L van der Wilt, B van Triest, et al.
Cancer Research|June 1, 1996
Inheritance of abnormal expression of SOS-like response in xeroderma pigmentosum and hereditary cancer-prone syndromesP J Abrahams, A Houweling, D M Cornelissen-Steijger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2002
Soluble aminopeptidase N/CD13 in malignant and nonmalignant effusions and intratumoral fluidYvette van Hensbergen, Henk J Broxterman, Roeland Hanemaaijer, et al.
British Journal of Cancer|May 11, 2006
CD13/Aminopeptidase N overexpression by basic fibroblast growth factor mediates enhanced invasiveness of 1F6 human melanoma cellsD Fontijn, M C A Duyndam, M P A van Berkel, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Phase II trial of anaxirone (TGU) in advanced colorectal cancer: an EORTC Early Clinical Trials Group (ECTG) studyE E Holdener, M Clavel, C Sessa, et al.
Sexually Transmitted Infections|October 13, 2017
High prevalence of high-risk HPV genotypes other than 16 and 18 in cervical cancers of Curaçao: implications for choice of prophylactic HPV vaccineDesiree J Hooi, Birgit I Lissenberg-Witte, Maurits N C de Koning, et al.
Pageof 69